PatientRightsAdvocate.org Launches New York City Hospital Price Finder
NEW YORK, May 12, 2025 /PRNewswire/ -- Today, PatientRightsAdvocate.org (PRA) announced the New York City Hospital Price Finder Tool, empowering all who are treated in New York City hospitals with free access to all available prices so they can compare, prevent overcharges, and have recourse for surprise bills. Patients, employers, unions, and researchers in New York City are now able to search all posted prices by hospital, procedure, plan, and code at NYCHospitalPrices.org.
"The New York City Hospital Price Finder Tool is a huge step for New York City healthcare consumers, who have long suffered from hidden healthcare prices, kept secret by hospitals and insurers alike," said Cynthia Fisher, Founder and Chairman of PRA. "This tool will enable patients to easily compare actual prices, including discounted cash rates, and choose the best care at a price they can afford. Now, patients will have financial certainty as well as safeguards when their bill doesn't match the price, to protect them from overcharges."
In December 2022, New York City Council Member Julie Menin sponsored Intro. 844-A to establish the nation's first Office of Health Care Accountability to equip New Yorkers with the upfront pricing information needed for healthcare decisions. In June 2023, the legislation passed unanimously and was signed into law.
"New Yorkers will no longer live in fear that medical care will put them in financial ruin. Following our work to establish the Office of Health Care Accountability, this tool is the next step to provide New Yorkers with the resources needed to find the highest quality of care at the best price," said New York City Council Member Julie Menin. "Now, patients can easily research ahead of medical decisions with peace of mind that New York City will enforce price transparency to safeguard their physical and financial well-being."
For many patients, this tool would have made an enormous difference. The Singh family of New York City is speaking out on the value of this service.
"With upfront and real prices, we would have been able to make an informed decision on how best to proceed with our son's treatments to best help his physical health and our family's financial health. If we had been able to compare in advance, we would have been willing to drive a little further, or perhaps even had a better option nearby, to avoid the tremendous debt that has burdened our family throughout an incredibly vulnerable time," said Shameeza Singh. "We hope this tool will be a powerful resource for every patient in New York City so that devastating medical debt stories are no more and families can instead fully focus on treatment and recovery."
The first of its kind in New York City, PRA recently introduced a similar tool in Colorado and has plans to continue expanding resources for patients across the country.
"Healthcare price transparency will deliver high quality care at lower costs for patients, but that starts with easy access to prices. The New York City Hospital Price Finder will allow New Yorkers to quickly compare healthcare prices across the city," said Manny Pastreich, President of 32BJ SEIU. "We need real transparency and accountability to make informed decisions and lower costs, and this resource is a strong step in that direction."
View more photos here. View Council Member Menin's remarks here.
PatientRightsAdvocate.org (PRA) is a leading national healthcare price transparency organization dedicated to ushering in systemwide transparency through advocacy, testimony, media, legal research, and grassroots campaigns. PRA believes that the availability and visibility of actual, upfront healthcare prices will greatly lower costs for patients and employers through a functional, competitive healthcare marketplace.
View original content to download multimedia:https://www.prnewswire.com/news-releases/patientrightsadvocateorg-launches-new-york-city-hospital-price-finder-302453067.html
SOURCE Patient Rights Advocate
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Knee Replacement Surgery Market worth $16.17 billion in 2030 with 6.1% CAGR
DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The global Knee Replacement Surgery Market, valued at US$10.86 billion in 2023 stood at US$12.00 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$16.17 billion by the end of the period. The key factor propelling the market is the increasing prevalence of osteoarthritis, particularly among the aging population. This increase in cases is driving a higher demand for surgical interventions, including total and partial knee replacements. As life expectancy increases and age-associated degenerative changes to the knee joint become more pronounced, the necessity for these procedures is escalating. This demographic shift is a significant catalyst for market expansion, contributing to a growing global patient population requiring knee treatment solutions. Download PDF Brochure: Browse in-depth TOC on "Knee Replacement Surgery Market" 300 - Tables55 - Figures400 - Pages By product, the global knee replacement surgery market is segmented into knee implants, knee braces & support systems, and orthobiologics. The orthobiologics segment is expected to register significant growth over the forecast period. A growing number of patients are opting for non-surgical interventions to manage their conditions. Orthobiologics, such as Platelet-Rich Plasma (PRP) therapy, stem cell treatments, and hyaluronic acid injections, provide less invasive alternatives that enhance healing and stimulate tissue regeneration. These modalities are particularly beneficial for patients with early to moderate osteoarthritis, where conventional surgical interventions may be premature or unnecessary. By application, the global knee replacement surgery market is segmented into osteoarthritis & rheumatoid arthritis, degenerative disease, cancer, and other applications. The Centers for Disease Control and Prevention (CDC) reports that approximately 319,000 individuals aged 65 and older are hospitalized annually in the United States due to hip fractures. Surgical intervention typically involves the use of fixation devices that stabilize the fractured bone by immobilizing it, thereby providing a protective framework that facilitates healing. The incorporation of orthobiologics into orthopedic procedures is gaining traction, as these biological agents enhance the regenerative capacity of tissues and promote faster recovery. With the increasing prevalence of conditions such as rheumatoid arthritis and osteoarthritis, coupled with a growing geriatric population, there is a projected surge in the adoption of knee surgery devices to address these joint pathologies effectively. By end user, the end user segment of the knee replacement surgery market includes hospitals, ambulatory surgery centers, and orthopedic clinics. In 2024, hospitals accounted for the largest market share. Recent advancements in surgical technologies, anesthesia techniques, and shifts in Medicare reimbursement policies have driven an escalation in orthopedic procedures within outpatient environments, particularly ambulatory surgery centers. These developments are poised to significantly enhance the expansion of the ASC market. Consequently, we can anticipate a marked increase in the volume of knee arthroplasties conducted in these settings, thereby further propelling the growth of the ASC segment in the near future. Request Sample Pages : As of 2024, prominent players in the knee replacement surgery market are Zimmer Biomet (US), Stryker (US), Johnson & Johnson, Inc. (US), Smith+Nephew PLC (UK), and B. Braun (Germany). Stryker (US): Stryker ranks among the top firms in the global knee replacement surgery market. The organization has established a formidable presence in the global market, extending its operational reach across key regions, including Europe, North America, the Middle East, Africa, and the Asia Pacific. With a successful track record in more than 75 countries, the company has effectively built a strong brand recognition, particularly through its Orthopedics division, which specializes in advanced surgical devices for knee treatments. Driven by a commitment to growth, the firm continuously seeks to broaden its product portfolio, ensuring that it remains at the forefront of innovation by launching groundbreaking solutions tailored to meet the evolving demands of the market. To maintain its competitive advantage, the organization places a high priority on innovation and the creation of unique, differentiated products that stand out in an increasingly crowded marketplace. A central element of its strategy is a substantial investment in R&D, which fuels the introduction of pioneering technologies. These advancements are specifically designed to address the pressing, unmet needs of healthcare providers and patients, thereby enhancing treatment outcomes and improving the quality of care within the healthcare system. Zimmer Biomet (US) Zimmer Biomet (US) is among the leading companies in the global knee replacement surgery market. The firm is a key player in the healthcare industry, specializing in the production and distribution of a diverse range of medical devices and healthcare products designed to meet various medical needs. With a robust presence across multiple international markets, the company operates in notable countries such as Germany, where it taps into a highly developed healthcare system; France, which is known for its emphasis on innovation in medicine; and Italy, which has a rich history of medical advancements. In addition to these European nations, the firm's influence extends to Switzerland, renowned for its high-quality healthcare, as well as Spain and the UK, both of which represent significant markets for medical technology. The firm also maintains a strong foothold in Asia, including major economies such as Japan and South Korea, which are recognized for their cutting-edge healthcare technologies. Further expanding its global reach, the firm has established a presence in China, one of the fastest-growing healthcare markets in the world, as well as in Australia and New Zealand, where it provides vital healthcare solutions. The company is also active in Taiwan, India, Hong Kong, Thailand, Singapore, and Malaysia, where it meets the diverse medical needs of these dynamic populations. To support its extensive operations, the firm has developed a comprehensive distribution network that spans Benelux (Belgium, Netherlands, and Luxembourg) and the Nordic countries, ensuring effective market penetration in Central and Eastern Europe. Additionally, the firm has made significant inroads in the Middle East and Africa, regions that are increasingly recognizing the importance of advanced medical technology in improving healthcare outcomes. This strategic global presence not only enhances the firm's competitiveness but also reinforces its commitment to advancing healthcare worldwide. Johnson & Johnson Services, Inc. (US) Johnson & Johnson Services, Inc. (US) is a prominent entity within the knee replacement surgery sector, engaged in the comprehensive manufacturing, R&D, and global marketing of joint replacement technologies and related healthcare products. Operating under the MedTech business segment, it specializes in advancing knee replacement surgery products aimed at improving clinical outcomes through innovative technology. In a strategic collaboration with CrossRoads Extremity Systems (US), the company is focused on enhancing orthopedic care by integrating novel ideas to provide patients with superior health benefits. The firm commands a substantial market share across more than 60 countries, spanning multiple regions, including Asia Pacific, North America, the Middle East & Africa, and Europe. Additionally, it operates through a robust portfolio of key subsidiaries, which includes DePuy, Inc. (US), Animas Corporation (US), Ethicon, Inc. (US), and LifeScan, Inc. (US). For more information, Inquire Now! Related Reports: Joint Replacement Devices Market Orthopedic Braces & Supports Market Medical Robots Market Surgical Robots Market Minimally Invasive Surgical Instruments Market Get access to the latest updates on Knee Replacement Surgery Companies and Knee Replacement Surgery Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets
Yahoo
a day ago
- Yahoo
RingConn Gen 2 Now Available on Walmart.com, Bringing Advanced Sleep Apnea Monitoring to More Consumers
LOS ANGELES, July 23, 2025 /PRNewswire/ -- RingConn, a leading smart ring innovator, has officially launched its flagship Gen 2 Smart Ring and accessories on marking a significant milestone in its U.S. retail expansion. This partnership with Walmart, the nation's largest retailer, enhances RingConn's mission to make advanced health technology more accessible to everyday consumers. As one of the fastest-growing categories in consumer technology, smart wearable devices have become a key area of investment for Walmart, supporting improvements in employee safety, warehouse efficiency, and customer service. In response to the rising demand for personalized, preventive health tools, Walmart has steadily expanded its health-focused wearable offerings this year, adding new-generation devices and advanced sleep tracking wearables. The arrival of RingConn marks a significant step in Walmart's ongoing product diversification strategy—moving beyond traditional wrist-worn formats to offer customers a more compact, discreet, and medically insightful solution. Leveraging its leading technology and innovative design, RingConn has quickly established itself as a benchmark brand in the smart ring segment. Unique features such as advanced sleep tracking, an integrated AI health partner, and ultra-lightweight craftsmanship have earned it recognition from over 200,000 users worldwide. The United States—one of the most mature health tech markets, where consumers value data privacy and proactive health management—has long been a core focus for RingConn. The brand has seen rapid growth in the U.S., becoming a trusted name in smart rings. With its launch on RingConn will leverage Walmart's scale to reach a broad, diverse consumer base and accelerate its North American expansion. The RingConn Gen 2 Smart Ring, now available at was launched in late 2024 and broke a Kickstarter category record with $4.4 million in crowdfunding. It's the world's first smart ring to offer sleep apnea monitoring. Besides, Gen 2 holds several technical distinctions: Lightest available model at 2-3 grams, and thinnest profile in its category at 2mm Extended battery life of 10-12 days Cross-platform compatibility (Android/iOS) with no subscription fees Advanced menstrual cycle monitoring feature To ensure optimal customer experience, Walmart consumers can first order a sizing kit to determine their perfect fit before purchasing the smart ring. This partnership with Walmart marks an important step in RingConn's mission to make smart, approachable health technology available to consumers. About RingConn Established in 2021, RingConn is a leading personal health technology company dedicated to creating innovative products and services that transform the experience of maintaining personal wellness. Guided by the principle of "Hardware + Software + Services," RingConn aims to provide unique products and services for people's health. View original content to download multimedia: SOURCE RingConn LLC
Yahoo
a day ago
- Yahoo
Blood Pressure Cuffs Market worth $1.3 billion in 2032 with 9.0% CAGR
DELRAY BEACH, Fla., July 23, 2025 /PRNewswire/ -- The global Blood Pressure Cuffs Market, valued at US$0.6 billion in 2024 stood at US$0.7 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2032, culminating in a forecasted valuation of US$1.3 billion by the end of the period. The increasing global burden of chronic non-communicable diseases, including hypertension, obesity, and cardiovascular disorders, primarily drives the expansion of the blood pressure monitoring market. These conditions significantly increase blood pressure levels, necessitating consistent monitoring and management. Moreover, heightened public and clinical awareness of hypertension and its associated complications has led to greater demand for effective diagnostic and monitoring solutions. Concurrently, market growth is further supported by continuous technological advancements and product innovation by key industry players. These developments include introducing non-invasive, automated, and wearable blood pressure monitoring devices to improve accuracy, usability, and patient compliance. Download PDF Brochure: Browse in-depth TOC on "Blood Pressure Cuffs Market" 376 - Tables 50 - Figures 309 - Pages By type, the blood pressure cuffs market is divided into automated and manual segments. Appropriately validated automated blood pressure measuring devices (BPMDs) are considered the preferred standard for clinical diagnosis and management of hypertension. The growth of the automated segment is primarily fueled by the increasing incidence of cardiovascular diseases and the widespread adoption of advanced technologies that offer greater accuracy, ease of use, and efficiency in blood pressure monitoring. By end users, the blood pressure cuffs market is segmented into hospitals, home care settings, ambulatory care centers, urgent care centers, primary centers, and other end users. As of 2024, the hospitals segment accounted for the largest market share. The large share of the segment can be attributed to the higher purchasing power of hospitals. Hospitals are equipped with advanced monitoring technologies and follow standardized clinical procedures, which ensure reliable blood pressure readings. The growing prevalence of cardiovascular diseases and the increasing number of hospital admissions, especially among the elderly population, further drive demand for high-quality blood pressure cuffs in these settings. By geography, the blood pressure cuffs market is segmented into five regional segments: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to grow at the highest CAGR of 10.8% during the forecast period. This rapid expansion is driven by several key factors, including emerging economies such as China, India, and Japan, which are experiencing a surge in healthcare demand. The rising incidence of chronic illnesses, particularly hypertension, and cardiovascular diseases, combined with a growing awareness of early diagnosis and disease prevention, is fueling market growth in the region. Request Sample Pages : The prominent players in the blood pressure cuffs market include OMRON Corporation, Inc. (Japan), Baxter International, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies, Inc. (US), and McKesson Corporation. (US), B Braun Melsungen AG (Germany), Halma plc (Uk), OSI Systems, Inc. (US), American Diagnostic Corporation (US), Medline Industries, LP. (US), Microlife Corporation (Switzerland), BIOS Medical (UK), ACCOSON (UK), CellBios (India), and Midmark Corporation (US), among others. BAXTER INTERNATIONAL INC. (US): Baxter International Inc., through its subsidiaries, provides a broad range of essential healthcare products, including diagnostic & patient monitoring technologies and respiratory care devices. These products are used in diverse healthcare environments such as hospitals, nursing homes, rehabilitation centers, ambulatory surgical centers, physicians' offices, and home care settings under medical supervision. The company operates globally through four main segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The Healthcare Systems and Technologies segment—connected care solutions, collaboration platforms, monitoring systems, and diagnostic tools such as blood pressure cuffs—is a key component of Baxter's overall strategy. OMRON CORPORATION (JAPAN) OMRON Corporation is a global leader known for offering a diverse portfolio of products across multiple industries. The company operates through four primary business segments: Industrial Automation, Healthcare Business, Social Systems, Solutions and Service Business, and Device & Module Solutions Business. OMRON Healthcare Co., Ltd., a subsidiary of Omron Corporation, specializes in medical devices and health management solutions. This division is recognized as a market leader in cardiovascular care, respiratory health, pain management, remote patient monitoring, and home healthcare equipment—particularly blood pressure monitors. MCKESSON CORPORATION (US) McKesson Corporation and its subsidiaries are a prominent provider of diverse healthcare services dedicated to improving patient health outcomes worldwide. The company operates through four main business segments: US Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The Medical-Surgical Solutions segment plays a key role in delivering a wide range of medical-surgical products—including blood pressure cuffs—as well as logistics, distribution, and support services to various healthcare providers such as physician offices, surgical centers, nursing homes, hospital labs, and home health care agencies. McKesson collaborates with manufacturers and channel partners to effectively serve these markets, focusing on key sectors such as primary care, extended care, government, and other healthcare markets. For more information, Inquire Now! Related Reports: Pulse Oximeter Market Patient Monitoring Devices Market Home Healthcare Market Respiratory Care Devices Market Pressure Monitoring Market Get access to the latest updates on Blood Pressure Cuffs Companies and Blood Pressure Cuffs Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
